Title
Amendments to R.A. No. 3720 on Food, Drugs and Cosmetics
Law
Executive Order No. 175
Decision Date
May 22, 1987
Executive Order No. 175 amends Republic Act No. 3720 to ensure the safety and purity of foods, drugs, and cosmetics, establish standards and quality measures, and impose penalties for violations, with the aim of protecting and promoting the right to health of the people in the Philippines.

Declaration of Policies

  • The State protects and promotes the right to health and health consciousness (Art II, Sec 15, 1987 Constitution).
  • The State establishes and maintains an effective food and drug regulatory system (Art XIII, Sec 12, 1987 Constitution).
  • Health manpower development and research responsive to country’s needs must be undertaken.

Government Responsibilities under the Act

  • Establish standards and quality measures for foods, drugs, devices, and cosmetics.
  • Ensure a pure and safe supply of foods and cosmetics; ensure drugs and devices are pure, safe, efficacious, and of good quality.
  • Promote rational drug and device use, including bans, recalls, and adopting a national formulary.
  • Strengthen the Bureau of Food and Drugs.

Key Definitions

  • "Bureau" means the Bureau of Food and Drugs.
  • "Drugs" includes articles recognized in official pharmacopeias; articles for diagnosis, cure, mitigation, treatment, or prevention of disease in humans/animals; agents affecting body structure or function excluding devices.
  • "New drugs" are those not generally recognized by experts or used extensively under new conditions, including newly discovered ingredients or combinations.
  • Additional terms defined include "batch," "batch number," "director," "distribute," "expiry date," "export," "import," "manufacture," and "new veterinary drugs."

Prohibited Acts

  • Manufacturing/importing/exporting/selling adulterated or misbranded foods, drugs, devices, or cosmetics.
  • Adulteration or misbranding.
  • Refusal of inspections or sample collection.
  • False guarantees or undertakings.
  • Forgery or misuse of identification marks.
  • Unauthorized use or disclosure of protected trade secrets.
  • Altering or removing labeling to cause adulteration or misbranding.
  • False drug efficacy claims or unauthorized reference to official reports.
  • Manufacture, sale, or distribution of unregistered or unlicensed drugs/devices.
  • Selling beyond expiration or releasing uncertified batches as required.

Penalties for Violations

  • Imprisonment of 1 to 5 years, or fines from ₱5,000 to ₱10,000, or both.
  • Penalties apply to corporate officers responsible.
  • Protection against penalties for good faith sales provided cooperation for information is given.

Criteria for Adulteration

  • Containing filthy, putrid, or decomposed substances.
  • Manufactured under unsanitary conditions.
  • Containing poisonous substances in containers.
  • Use of unauthorized coloring agents.
  • Failing to meet prescribed standards for strength, safety, efficacy, quality, or purity.
  • Mixing or substitution of substances reducing safety or quality.
  • Non-conformance with good manufacturing practices.

Criteria for Misbranding

  • False or misleading labeling.
  • Labeling omissions concerning manufacturer, contents, directions, warnings.
  • Inadequate disclosure of habit-forming substances or narcotics.
  • Improper packaging or misleading container.
  • Dangerous under prescribed usage.
  • Uncertified antibiotic drugs.

Labeling and Packaging Regulations

  • Exemptions allowed for drugs processed or repacked in other establishments if compliance is assured.
  • Habit-forming, toxic, or new investigational drugs require prescription.
  • Violations in dispensing or labeling are acts of misbranding.

Licensing, Registration, and Product Approval

  • No manufacture, sale, import, export, distribution or transfer of drugs/devices without license and registration.
  • Application for registration includes safety, efficacy, composition, manufacturing methods, labeling, and samples.
  • Secretary must approve or deny application within 180 days or grant a hearing.
  • Authority to suspend effectiveness of approval if safety or truthfulness issues arise.
  • Regulations exempt investigational use drugs.

Certification of Antibiotic Drug Batches

  • Certification required for safety, identity, strength, quality, and purity.
  • Provisions for issuing releases before certification regulations are in place.
  • Exemptions for certain drug classes and investigational drugs.

Administrative Provisions and Sanctions

  • Secretary empowered to issue necessary rules and regulations.
  • Customs and Health Officials coordinate to enforce import regulations.
  • Hearings and proceedings conducted by the Bureau.
  • Secretary authorized to impose administrative fines from ₱1,000 to ₱5,000.

Importation and Customs Control

  • Customs to sample imported shipments for compliance.
  • Refused goods destroyed or exported within a prescribed time.
  • Relabeling or other compliance measures allowed under supervision.
  • Costs for destruction, storage, or supervision charged to owner or consignee.
  • Exported products are exempt from adulteration/misbranding if properly labeled and meet foreign requirements.

Repeal and Effectivity

  • Repeals inconsistent laws, orders, or rules.
  • The executive order takes effect 15 days after publication in the Official Gazette.

Analyze Cases Smarter, Faster
Jur helps you analyze cases smarter to comprehend faster—building context before diving into full texts.